Method for separating and measuring lurasidone hydrochloride intermediate related substances through liquid chromatography
A technology for lurasidone hydrochloride and its determination method, which is applied in the field of separation and determination of lurasidone hydrochloride intermediates and related substances by liquid chromatography, and can solve the problem of incomplete removal of impurities, side reaction impurities, and influence on drug purity and quality and other issues to achieve the effect of ensuring purity, reducing side reactions, and quality control
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] Instruments and Conditions
[0039] High performance liquid chromatography: Shimadzu: LC-20AT, CBM-20A, SIL-20AC, SPD-M20A, CTO-10ASvp
[0040] Chromatographic column: C8 (Phenomenex, 250×4.6 mm, 5 μm)
[0041] Mobile phase: A: 20 mmol / L potassium dihydrogen phosphate and 10 mmol / L sodium heptanesulfonate solution (pH 6.0)
[0042] B: Acetonitrile
[0043] Flow rate: 1.0 mL / min
[0044] Detection wavelength: 230 nm
[0045] Injection volume: 10 μL
[0046] time (min) mobile phase A mobile phase B 0 70 30 12 70 30 17 58 42 27 40 60 32 70 30 50 70 30
[0047] Experimental procedure
[0048] Take an appropriate amount of lurasidone hydrochloride intermediate and its related substances, dissolve it in methanol, and prepare a solution containing 0.5 mg of lurasidone hydrochloride intermediate and its related substances per 1 mL. Take an appropriate amount of the above-mentioned lurasidone hydrochloride intermediate ...
Embodiment 2
[0050] Instruments and Conditions
[0051] High performance liquid chromatography: Shimadzu: LC-20AT, CBM-20A, SIL-20AC, SPD-M20A, CTO-10ASvp
[0052] Chromatographic column: C8 (Phenomenex, 250×4.6 mm, 5 μm)
[0053] Mobile phase: A: 20 mmol / L potassium dihydrogen phosphate and 10 mmol / L sodium heptanesulfonate solution (pH 6.0)
[0054] B: Acetonitrile
[0055] Flow rate: 1.0 mL / min
[0056] Detection wavelength: 230 nm
[0057] Injection volume: 10 μL
[0058] time (min) mobile phase A mobile phase B 0 70 30 12 70 30 17 58 42 30 45 55 40 70 30 50 70 30
[0059] Experimental procedure
[0060] Take an appropriate amount of lurasidone hydrochloride intermediate and its related substances, dissolve it in methanol, and prepare a solution containing 0.5 mg of lurasidone hydrochloride intermediate and its related substances per 1 mL. Take an appropriate amount of the above-mentioned lurasidone hydrochloride intermediate ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com